Clinical trial
Biomarkers in Patients Undergoing Transrectal Ultrasound Prostate Biopsy
NCT00373035 · Wake Forest University Health Sciences, Other · Completed
Key facts
| NCT number | NCT00373035 |
|---|---|
| Title | Biomarkers in Patients Undergoing Transrectal Ultrasound Prostate Biopsy |
| Official title | Biomarkers of Prostate Cancer |
| Lead sponsor | Wake Forest University Health Sciences, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Prostate Cancer |
| Intervention type | Genetic, Other, Procedure |
| Interventions | proteomic profiling, immunological diagnostic method, laboratory biomarker analysis, mass spectrometry, biopsy, ultrasound imaging |
| Enrollment | 60 |
| Start date | Feb 1, 2006 |
| Primary completion | Jul 1, 2006 |
| First posted | Sep 7, 2006 |
| Last update posted | Jan 19, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: